<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02421055</url>
  </required_header>
  <id_info>
    <org_study_id>15SM2479</org_study_id>
    <nct_id>NCT02421055</nct_id>
  </id_info>
  <brief_title>Longitudinal Phenotyping of Bariatric Surgery Patients</brief_title>
  <official_title>Longitudinal Phenotyping of Bariatric Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent studies have shown that bacteria within the gut play an important role in diabetes&#xD;
      improvement after bariatric (weight-loss) surgery. Bariatric surgery fundamentally changes&#xD;
      the environment within the gut, which results in changes to the makeup of the trillions of&#xD;
      bacteria living within it. These changes in the gut bacteria can affect the body in a number&#xD;
      of complex ways, which we are only just beginning to understand. For example, gut bacteria&#xD;
      breakdown food we are unable to absorb ourselves, leading to altered sugar levels and can&#xD;
      release molecules that act to reduce appetite.&#xD;
&#xD;
      In this study we aim to find out how bariatric surgery changes the gut bacteria and how this&#xD;
      leads to weight loss and improvement of diabetes. With this understanding we hope to discover&#xD;
      potential targets for future treatments, such as identifying beneficial bacteria that could&#xD;
      be supplemented with probiotics in patients.&#xD;
&#xD;
      Additionally, although highly successful, up to 30% of obese patients do not undergo&#xD;
      improvement of their diabetes after bariatric surgery. We aim to identify molecules within&#xD;
      the patient's blood or urine that are able to predict the likely chance a patient will&#xD;
      undergo improvement in their diabetes after bariatric surgery to help clinicians select&#xD;
      patients most likely to benefit.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to assess how the gut microbiome affects the host phenotype following&#xD;
      bariatric surgery through altered gut microbiome-host co-metabolism. The secondary objective&#xD;
      is to identify novel biomarkers for the preoperative prognostication of T2DM remission&#xD;
      following bariatric surgery.&#xD;
&#xD;
      The study will longitudinally phenotype obese diabetics and non-diabetics undergoing&#xD;
      Roux-en-Y Gastric Bypass or Sleeve Gastrectomy surgery. Patients will be assessed&#xD;
      preoperatively and at 3 months and 1 year postoperatively. Clinical measures recorded will&#xD;
      include; 1) anthropometric &amp; physiological measurements, 2) demographic details, 3)&#xD;
      biochemical parameters including HbA1c, 4) anti-hyperglycaemic and other medication use, 5)&#xD;
      co-morbidity status and 6) dietary choices through 24hr dietary recall questionnaires.&#xD;
&#xD;
      Blood, urine and stool samples will be collected at the above time points. Changes to the&#xD;
      microbiome will be assessed using metagenomic sequencing. Global metabonomic profiles of&#xD;
      serum, urine and faecal water will be generated using 1H-NMR. Further targeted analyses of&#xD;
      bile acid and short-chain fatty acid profiles will be performed using LC-MS / GC-MS.&#xD;
&#xD;
      The study will utilise multivariate statistical analysis techniques to identify metabolic&#xD;
      pathways altered following intervention, and novel host-microbiome co-metabolism pathways&#xD;
      that impact upon phenotype. A supervised multivariate analysis, mapping T2DM outcomes to&#xD;
      metagenomic and metabonomic data will be performed with the aim of identifying novel&#xD;
      preoperative biomarkers that are able to prognosticate T2DM resolution following bariatric&#xD;
      surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">February 2019</completion_date>
  <primary_completion_date type="Actual">February 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Number of Participants With Complete Diabetes Remission at 3 Months</measure>
    <time_frame>3 months</time_frame>
    <description>Participants with HbA1c &lt;6% (42mmol/mol), off anti-diabetic medication, at 3 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Partial Diabetes Remission</measure>
    <time_frame>3 months</time_frame>
    <description>HbA1c &lt;6.5% (48mmol/mol), off anti-diabetic medication, at 3 months. (Includes participants with complete remission).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c Improvement</measure>
    <time_frame>3 months</time_frame>
    <description>Reduction in HbA1c at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>3 months</time_frame>
    <description>Weight loss at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI Reduction</measure>
    <time_frame>3 months</time_frame>
    <description>BMI reduction at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete Diabetes Remission</measure>
    <time_frame>1 year</time_frame>
    <description>HbA1c &lt;6% (42mmol/mol), off anti-diabetic medication, at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial Diabetes Remission</measure>
    <time_frame>1 year</time_frame>
    <description>HbA1c &lt;6.5% (48mmol/mol), off anti-diabetic medication, at 1 year. (Includes participants with complete diabetes remission).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c Improvement</measure>
    <time_frame>1 year</time_frame>
    <description>Reduction in HbA1c at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>1 year</time_frame>
    <description>Weight loss at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI Reduction</measure>
    <time_frame>1 year</time_frame>
    <description>BMI reduction at 1 year</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">158</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Roux-en-Y Gastric Bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Sleeve Gastrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Roux-en-Y Gastric Bypass</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Sleeve Gastrectomy</intervention_name>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, urine and stool preoperatively and at 3 months and 1 year postoperatively.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with obesity undergoing bariatric surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Obese (BMI&gt;30kg/m2)&#xD;
&#xD;
          -  Type 2 Diabetes Mellitus and non-diabetic&#xD;
&#xD;
          -  Failure of efforts at lifestyle modification and dieting&#xD;
&#xD;
          -  Fitness for anaesthesia and procedure&#xD;
&#xD;
          -  Willingness to comply with the trial protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous bariatric surgery&#xD;
&#xD;
          -  Pregnancy or intention to become pregnant during trial period&#xD;
&#xD;
          -  Lack of capacity to consent&#xD;
&#xD;
          -  Previous major abdominal surgery (Small or large bowel resection, stomach, liver,&#xD;
             pancreatic or splenic surgery. Does not include patients who have previously had an&#xD;
             appendicectomy, cholecystectomy or hernia repair).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ara Darzi, MB, BCh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imperial Weight Centre</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>April 15, 2015</study_first_submitted>
  <study_first_submitted_qc>April 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2015</study_first_posted>
  <results_first_submitted>August 11, 2020</results_first_submitted>
  <results_first_submitted_qc>October 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 6, 2020</results_first_posted>
  <last_update_submitted>October 15, 2020</last_update_submitted>
  <last_update_submitted_qc>October 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bariatric Surgery</keyword>
  <keyword>Gastric Bypass</keyword>
  <keyword>Sleeve Gastrectomy</keyword>
  <keyword>Gastroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 16, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/55/NCT02421055/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Some participants consented to give serum samples only, others were able to give complete sets of serum, 24-hour urine and stool, as detailed below.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Pre-operative Only</title>
          <description>Recruited patients that did not undergo RYGB or VSG procedures</description>
        </group>
        <group group_id="P2">
          <title>Roux-en-Y Gastric Bypass (RYGB)</title>
          <description>Participants who underwent RYGB procedure</description>
        </group>
        <group group_id="P3">
          <title>Vertical Sleeve Gastrectomy (VSG)</title>
          <description>Participants who underwent VSG procedure</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Pre-operative Serum Sample (Minimum)</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Pre-operative Complete Sample Set</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Post-operative Serum Sample (Minimum)</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Post-operative Complete Sample Set</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants with at least one pre-operative serum sample</population>
      <group_list>
        <group group_id="B1">
          <title>Roux-en-Y Gastric Bypass (RYGB)</title>
          <description>50 participants gave pre-operative serum samples prior to undergoing RYGB. 23 participants underwent RYGB and gave serum samples pre and 3-months post-operatively.&#xD;
13 of these gave complete sample sets of serum, 24-hour urine and stool pre and 3-months post-operation.</description>
        </group>
        <group group_id="B2">
          <title>Vertical Sleeve Gastrectomy (VSG)</title>
          <description>74 participants gave pre-operative serum samples prior to undergoing VSG. 26 participants underwent VSG and gave serum samples pre and 3-months post-operatively.&#xD;
14 of these gave complete sample sets of serum, 24-hour urine and stool pre and 3-months post-operation.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="124"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.54" spread="11.04"/>
                    <measurement group_id="B2" value="44.01" spread="11.91"/>
                    <measurement group_id="B3" value="45.03" spread="11.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (Kg)</title>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120.86" spread="20.17"/>
                    <measurement group_id="B2" value="133.6" spread="30.35"/>
                    <measurement group_id="B3" value="128.14" spread="27.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (kg/m2)</title>
          <units>Kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.43" spread="5.69"/>
                    <measurement group_id="B2" value="47.12" spread="8.99"/>
                    <measurement group_id="B3" value="46.03" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Type 2 Diabetes (T2D)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Impaired Glucose Tolerence (IGT)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non-diabetic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HBA1c</title>
          <units>mmols/mol</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.24" spread="17.66"/>
                    <measurement group_id="B2" value="45.41" spread="12.82"/>
                    <measurement group_id="B3" value="48.16" spread="15.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Metformin use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insulin use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="74"/>
                    <count group_id="B3" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of T2D (years)</title>
          <population>T2D participants only</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="24"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.96" spread="7.03"/>
                    <measurement group_id="B2" value="7.75" spread="8.47"/>
                    <measurement group_id="B3" value="7.86" spread="7.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Complete Diabetes Remission at 3 Months</title>
        <description>Participants with HbA1c &lt;6% (42mmol/mol), off anti-diabetic medication, at 3 months</description>
        <time_frame>3 months</time_frame>
        <population>Participants with complete follow up data</population>
        <group_list>
          <group group_id="O1">
            <title>Roux-en-Y Gastric Bypass</title>
            <description>Participants who underwent Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Vertical Sleeve Gastrectomy</title>
            <description>Participants who underwent Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Complete Diabetes Remission at 3 Months</title>
          <description>Participants with HbA1c &lt;6% (42mmol/mol), off anti-diabetic medication, at 3 months</description>
          <population>Participants with complete follow up data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Partial Diabetes Remission</title>
        <description>HbA1c &lt;6.5% (48mmol/mol), off anti-diabetic medication, at 3 months. (Includes participants with complete remission).</description>
        <time_frame>3 months</time_frame>
        <population>Participants with complete follow up data</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>Partial Diabetes Remission</title>
          <description>HbA1c &lt;6.5% (48mmol/mol), off anti-diabetic medication, at 3 months. (Includes participants with complete remission).</description>
          <population>Participants with complete follow up data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HbA1c Improvement</title>
        <description>Reduction in HbA1c at 3 months</description>
        <time_frame>3 months</time_frame>
        <population>Participants attending follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>HbA1c Improvement</title>
          <description>Reduction in HbA1c at 3 months</description>
          <population>Participants attending follow up</population>
          <units>mmols/mol</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.0" spread="11.98"/>
                    <measurement group_id="O2" value="7.53" spread="10.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight Loss</title>
        <description>Weight loss at 3 months</description>
        <time_frame>3 months</time_frame>
        <population>Participants attending follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Loss</title>
          <description>Weight loss at 3 months</description>
          <population>Participants attending follow up</population>
          <units>Kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.13" spread="9.13"/>
                    <measurement group_id="O2" value="24.00" spread="7.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>BMI Reduction</title>
        <description>BMI reduction at 3 months</description>
        <time_frame>3 months</time_frame>
        <population>Participants attending follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>BMI Reduction</title>
          <description>BMI reduction at 3 months</description>
          <population>Participants attending follow up</population>
          <units>Kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.87" spread="2.99"/>
                    <measurement group_id="O2" value="8.51" spread="2.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complete Diabetes Remission</title>
        <description>HbA1c &lt;6% (42mmol/mol), off anti-diabetic medication, at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>Participants with complete follow up data</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>Complete Diabetes Remission</title>
          <description>HbA1c &lt;6% (42mmol/mol), off anti-diabetic medication, at 1 year</description>
          <population>Participants with complete follow up data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Partial Diabetes Remission</title>
        <description>HbA1c &lt;6.5% (48mmol/mol), off anti-diabetic medication, at 1 year. (Includes participants with complete diabetes remission).</description>
        <time_frame>1 year</time_frame>
        <population>Participants with complete follow up data</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>Partial Diabetes Remission</title>
          <description>HbA1c &lt;6.5% (48mmol/mol), off anti-diabetic medication, at 1 year. (Includes participants with complete diabetes remission).</description>
          <population>Participants with complete follow up data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HbA1c Improvement</title>
        <description>Reduction in HbA1c at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>Participants attending follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>HbA1c Improvement</title>
          <description>Reduction in HbA1c at 1 year</description>
          <population>Participants attending follow up</population>
          <units>mmols/mol</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.72" spread="13.71"/>
                    <measurement group_id="O2" value="6.88" spread="10.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight Loss</title>
        <description>Weight loss at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>Participants attending follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Loss</title>
          <description>Weight loss at 1 year</description>
          <population>Participants attending follow up</population>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.53" spread="11.36"/>
                    <measurement group_id="O2" value="35.23" spread="12.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>BMI Reduction</title>
        <description>BMI reduction at 1 year</description>
        <time_frame>1 year</time_frame>
        <population>Participants attending follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Roux-en-Y Gastric Bypass</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Vertical Sleeve Gastrectomy</description>
          </group>
        </group_list>
        <measure>
          <title>BMI Reduction</title>
          <description>BMI reduction at 1 year</description>
          <population>Participants attending follow up</population>
          <units>Kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="3.69"/>
                    <measurement group_id="O2" value="13.02" spread="5.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Serious, and other adverse events were not monitored/assessed. None occurred as a result of this observational study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Pre-operative Samples Only</title>
          <description>Recruited patients that did not undergo RYGB or VSG procedures</description>
        </group>
        <group group_id="E2">
          <title>Roux-en-Y Gastric Bypass</title>
          <description>Participants who underwent RYGB</description>
        </group>
        <group group_id="E3">
          <title>Vertical Sleeve Gastrectomy</title>
          <description>Participants who underwent VSG</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="74"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Complete sets of serum, 24-hour urine and faeces were not collected from all participants. Details are described in baseline group descriptions.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Nicholas Penney</name_or_title>
      <organization>Imperial College London</organization>
      <phone>020 7589 5111</phone>
      <email>n.penney@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

